Clinical trial · Interventional
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate
Comparative Evaluation of New Surgical Robotic Platforms for the Radical Prostatectomy Procedure
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The object of this exploratory clinical trial is to evaluate post-operative complications in a population that underwent Robotic Assisted Radical Prostatectomy (RARP) made with multiple platforms: * DaVinci; * Hugo; * Versius. The questions it aims to answer are: * Does the estimation of the post-operative complications suggest something? * Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to fill out questionnaires and join one of these three groups: 1. surgery with the daVinci platform; 2. surgery with the Hugo platform; 3. surgery with the Versius platform.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DaVinci RARP | Device | — | UNRESOLVED |
| Hugo RARP | Device | — | UNRESOLVED |
| Versius RARP | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- DaVinci system
- description
- Robot-assisted radical prostatectomy is carried out through daVinci platform.
- interventionNames
- Device: DaVinci RARP
- type
- EXPERIMENTAL
- label
- Hugo system
- description
- Robot-assisted radical prostatectomy is carried out through Hugo platform.
- interventionNames
- Device: Hugo RARP
- type
- EXPERIMENTAL
- label
- Versius system
- description
- Robot-assisted radical prostatectomy is carried out through Versius platform.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 and \< 90 years; * Organ-localized prostate cancer with a surgical indication of radical prostatectomy; * Informed consent provided. Exclusion Criteria: * Age \< 18 and \> 90 years; * Contraindication to radical prostatectomy procedure; * Non-organ confined prostate cancer; * Refusal to participate.
References
Publications (1)
- DERIVEDAntonelli A, Veccia A, Malandra S, De Marco V, Rizzetto R, Gozzo A, Bianchi A, Brunelli M, Noale M, Cerruto MA, Bertolo R; University of Verona Residency Program in Urology. Six-month outcomes of a three-arm prospective study comparing Da Vinci vs. Hugo RAS vs. versius robotic radical prostatectomy: (the COMPAR-P trial). J Robot Surg. 2026 Mar 19;20(1):361. doi: 10.1007/s11701-026-03260-5. PMID 41851411